Does Eggshell Membrane Help Joints? | The Clinical Evidence

One wrong step sends a spike of pain through a worn knee, and the search for something that actually works begins. Natural eggshell membrane — specifically the branded ingredient NEM® — has emerged from multiple clinical trials as a legitimate option. The evidence shows it reduces pain by 23–35% over 60 days, with measurable changes appearing far faster than most joint supplements promise. Here is what the research actually says about dosage, timing, and who should avoid it.

What Exactly Is Natural Eggshell Membrane?

Natural eggshell membrane is the thin layer between the eggshell and the egg white. The branded ingredient NEM® is a specific, trademarked form of this membrane that has been standardized for supplement use. Supplied by Stratum Nutrition and manufactured by ESM Technologies, it contains naturally occurring glycosaminoglycans, collagen, proteins, amino acids, and type 2 collagen — all compounds essential for joint health.

The critical distinction is that NEM® is not generic crushed eggshell. Common eggshell powder lacks the membrane layer, which is where the joint-supporting compounds live. Only the membrane itself has been tested in clinical trials.

Does It Work for Knee Osteoarthritis?

The clinical evidence for NEM® in knee osteoarthritis is the strongest of any joint condition. Multiple randomized, double-blind, placebo-controlled trials have confirmed its effects. A 2024 meta-analysis published in the Journal of Functional Foods found that NEM® supplementation improved total WOMAC scores (pain plus function) compared to placebo. An earlier landmark study published in PubMed (ID 19340512) reported a 23% average reduction in osteoarthritic knee pain and a 12.8% reduction in stiffness scores.

The most striking finding is the speed of response. Significant pain reduction appears within 10 days, with a 15.9% drop reported in that short window. At 60 days, pain-related question scores improved by 35.6% in the active treatment group. The response rate — the percentage of people who experienced meaningful improvement — reached 26.6% for NEM® compared to placebo.

How Much Do You Take, and For How Long?

The standard dosage used across all clinical trials is 500 mg taken once daily. This is the amount confirmed effective in the primary human studies. Some trials included a high-dose group that achieved maximum pain reduction values, confirming a dose-dependent response — meaning higher doses produced stronger effects within the safe range.

Clinical studies typically run for 8 to 9 weeks (56 to 60 days). The rapid onset at day 10 means many people notice improvement within the first week and a half, but the full benefit accumulates over the full study period. NEM® is well-tolerated with or without food, and no serious adverse events have been reported across five clinical trials.

Does It Beat Glucosamine?

Direct head-to-head trials are limited, but the available data points to a meaningful difference in onset speed. Glucosamine typically requires 4 to 12 weeks before users report noticeable improvement. NEM® shows measurable pain reduction at 10 days. NEM® also provides naturally occurring glycosaminoglycans and type 2 collagen in a single ingredient, whereas glucosamine requires combination formulas to achieve a similar range of joint-supporting compounds.

That said, the two supplements work through different mechanisms. Some people take both, and no interactions have been reported. One trial noted NEM® is effective enough that it may outperform glucosamine for rapid pain relief, but individual results vary.

Joint Pain and Stiffness Results: The Data

The table below summarizes the key clinical outcomes from the primary human studies.

What the Negative Findings Mean

Not every study reported uniform success. One meta-analysis from Natural Health Research noted that NEM® did not significantly improve the Visual Analog Scale for pain in all patient groups. Another found that knee stiffness did not significantly improve across all participants, even when pain and function did. This matters because it sets realistic expectations: NEM® is a symptom management tool, not a cure for osteoarthritis progression. It reduces pain and improves function for a majority of users, but a subset of people may not experience stiffness relief.

For a practical comparison of products that contain the NEM® ingredient, our eggshell membrane supplement roundup covers the brands that use the clinically tested dosage.

Safety: Who Should Avoid This Supplement?

The safety profile of NEM® is excellent. No serious adverse events have been reported across any of the five human clinical trials. The two minor incidents noted were a scratchy throat (linked to concurrent antibiotic use) and mild stomach discomfort.

The absolute contraindication is egg allergy. Anyone with a known egg allergy must avoid NEM® entirely, as it is derived directly from eggshell membrane. For everyone else, NEM® is considered safe at doses of 300–500 mg daily for up to 12 weeks. Animal studies found no toxicity at doses up to 2000 mg per kg of body weight.

The “Thin Evidence” Warning You Should Know

McGill University’s Office for Science and Society has raised a credible caution: the human evidence for eggshell membrane, while positive, is thinner than the animal data. Five randomized trials is a modest body of evidence compared to decades of research on glucosamine or chondroitin. The animal studies — particularly the rat models of collagen-induced rheumatoid arthritis — showed dramatic reductions in inflammation markers (30–72% drops) and histopathology scores, but human data does not yet match that scale of effect.

This is not a reason to dismiss NEM®. It is a reason to understand the evidence on its own terms: the human trials are small but consistently positive, and the safety profile is strong enough to make NEM® a low-risk option worth trying for moderate osteoarthritis.

Common Mistakes People Make With Eggshell Membrane

The most frequent error is using generic crushed eggshells instead of the NEM® membrane. Regular eggshell powder lacks the glycosaminoglycan and collagen content of the membrane and has not been tested for joint health. A second mistake is under-dosing — taking less than 500 mg per day, which falls below the clinically confirmed threshold. Third, expecting immediate stiffness relief when the data shows pain drops first, and stiffness may lag or not improve at all. Fourth, treating it as a cure for osteoarthritis rather than a symptom management tool. Fifth, dismissing the McGill warning without weighing it against the consistent positive results from multiple independent trials.

How to Take NEM®: The Protocol That Works